The One Stock You Must Watch
An industry-shattering disruption is coming - this microcap is at the heart of it.
Click for ticker & full details

HOWL Insider Trading (Werewolf Therapeutics)

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $40,230.00

Werewolf Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Werewolf Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Werewolf Therapeutics Share Price & Price History

Current Price: $4.54
Price Change: Price Decrease of -0.2 (-4.22%)
As of 05/16/2022 04:17 PM ET

This chart shows the closing price history over time for HOWL up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
The American Antidote for Chinese Lithium?
Switching to renewable energy means lithium demand could skyrocket 1,000% by 2030. But China controls 80% of the world's lithium supply, and the U.S. warns that China's monopoly is a national security and economic threat. Nevada's famed lithium deposits could be the best antidote to fight back against Chinese lithium domination.
See Why Nevada Lithium Should be on Your Radar

Werewolf Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/15/2021Reid LeonardCOOSell3,000$13.41$40,230.00View SEC Filing Icon  
5/4/2021Bioventures 2014 L.P. MpmMajor ShareholderBuy125,759$16.00$2,012,144.00View SEC Filing Icon  
5/4/2021Ra Capital Management, L.P.DirectorBuy1,715,000$16.00$27,440,000.00View SEC Filing Icon  
See Full Table
27 U.S. Cities Where Stocks Yield 26% a Year
What’s the highest-yielding stock you’ve ever owned? The dividends for these stocks have risen so fast over the years that they’re now yielding us an average of 26%!

When you start getting paid 26% on your money, your financial problems tend to pretty much evaporate.
Get in on the action here.

SEC Filings (Institutional Ownership Changes) for Werewolf Therapeutics (NASDAQ:HOWL)

72.69% of Werewolf Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at HOWL by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Werewolf Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/16/2022State Street Corp335,087$1.47M0.0%+29.1%1.212%Search for SEC Filing on Google Icon
5/13/2022Northern Trust Corp195,068$0.86M0.0%-2.5%0.705%Search for SEC Filing on Google Icon
5/13/2022Vanguard Group Inc.522,087$2.30M0.0%-1.0%1.888%Search for SEC Filing on Google Icon
5/12/2022BlackRock Inc.1,283,545$5.65M0.0%+0.6%4.641%Search for SEC Filing on Google Icon
5/12/2022Rhumbline Advisers22,550$99K0.0%+16.8%0.082%Search for SEC Filing on Google Icon
5/11/2022Bank of New York Mellon Corp68,338$0.30M0.0%+5.5%0.247%Search for SEC Filing on Google Icon
5/11/2022Granite Point Capital Management L.P.55,000$0.24M0.1%+266.7%0.199%Search for SEC Filing on Google Icon
5/11/2022JPMorgan Chase & Co.15,627$68K0.0%-44.3%0.057%Search for SEC Filing on Google Icon
2/23/2022BlackRock Inc.1,276,208$15.20M0.0%+245.0%4.627%Search for SEC Filing on Google Icon
2/19/2022Wells Fargo & Company MN12,699$0.15M0.0%N/A0.046%Search for SEC Filing on Google Icon
2/17/2022Goldman Sachs Group Inc.10,080$0.12M0.0%N/A0.037%Search for SEC Filing on Google Icon
2/16/2022The Manufacturers Life Insurance Company 12,831$0.15M0.0%N/A0.047%Search for SEC Filing on Google Icon
2/16/2022Deutsche Bank AG16,047$0.19M0.0%+268.8%0.058%Search for SEC Filing on Google Icon
2/16/2022California State Teachers Retirement System14,434$0.17M0.0%+257.1%0.052%Search for SEC Filing on Google Icon
2/15/2022Metropolitan Life Insurance Co NY8,460$0.10M0.0%N/A0.031%Search for SEC Filing on Google Icon
2/15/2022MetLife Investment Management LLC11,421$0.14M0.0%N/A0.041%Search for SEC Filing on Google Icon
2/15/2022Susquehanna International Group LLP11,829$0.14M0.0%N/A0.043%Search for SEC Filing on Google Icon
2/15/2022Legal & General Group Plc2,492$30K0.0%+238.6%0.009%Search for SEC Filing on Google Icon
2/15/2022Adage Capital Partners GP L.L.C.960,448$11.44M0.0%-2.5%3.483%Search for SEC Filing on Google Icon
2/14/2022Deerfield Management Company L.P. Series C958,125$11.41M0.2%-45.3%3.474%Search for SEC Filing on Google Icon
2/14/2022State Street Corp259,626$3.09M0.0%+123.7%0.941%Search for SEC Filing on Google Icon
2/14/2022Goldman Sachs Group Inc.10,080$0.12M0.0%N/A0.037%Search for SEC Filing on Google Icon
2/14/2022Nuveen Asset Management LLC36,879$0.73M0.0%+84.7%0.134%Search for SEC Filing on Google Icon
2/14/2022Soleus Capital Management L.P.64,585$0.77M0.1%-88.5%0.234%Search for SEC Filing on Google Icon
2/11/2022Granite Point Capital Management L.P.15,000$0.18M0.0%N/A0.054%Search for SEC Filing on Google Icon
2/11/2022Geode Capital Management LLC214,224$2.55M0.0%+57.0%0.777%Search for SEC Filing on Google Icon
2/11/2022Charles Schwab Investment Management Inc.60,594$0.72M0.0%+212.0%0.220%Search for SEC Filing on Google Icon
2/10/2022Rhumbline Advisers19,305$0.23M0.0%N/A0.070%Search for SEC Filing on Google Icon
2/10/2022JPMorgan Chase & Co.28,057$0.33M0.0%+629.1%0.102%Search for SEC Filing on Google Icon
2/10/2022Citigroup Inc.7,920$94K0.0%+813.5%0.029%Search for SEC Filing on Google Icon
2/8/2022Bank of America Corp DE28,265$0.34M0.0%+4,466.2%0.102%Search for SEC Filing on Google Icon
2/8/2022Northern Trust Corp200,065$2.38M0.0%+184.2%0.725%Search for SEC Filing on Google Icon
11/18/2021Bank of New York Mellon Corp29,789$0.51M0.0%+34.1%0.108%Search for SEC Filing on Google Icon
11/16/2021UBS Group AG1,639$28K0.0%+63.9%0.006%Search for SEC Filing on Google Icon
11/15/2021Deerfield Management Company L.P. Series C1,752,787$30.08M0.6%-31.3%6.358%Search for SEC Filing on Google Icon
11/15/2021California State Teachers Retirement System4,042$69K0.0%-61.4%0.015%Search for SEC Filing on Google Icon
11/15/2021Morgan Stanley1,514$26K0.0%+467.0%0.005%Search for SEC Filing on Google Icon
11/15/2021Sphera Funds Management LTD.688,475$11.81M1.0%-2.5%2.497%Search for SEC Filing on Google Icon
11/15/2021Caas Capital Management LP162,599$2.79M0.1%+62.6%0.590%Search for SEC Filing on Google Icon
11/12/2021Geode Capital Management LLC136,472$2.34M0.0%+26.2%0.495%Search for SEC Filing on Google Icon
11/10/2021Levin Capital Strategies L.P.15,000$0.26M0.0%N/A0.054%Search for SEC Filing on Google Icon
11/9/2021BlackRock Inc.369,961$6.35M0.0%+1.1%1.342%Search for SEC Filing on Google Icon
11/9/2021Platinum Investment Management Ltd.213,381$3.66M0.1%+3.1%0.774%Search for SEC Filing on Google Icon
11/8/2021Russell Investments Group Ltd.125,873$2.16M0.0%N/A0.457%Search for SEC Filing on Google Icon
11/2/2021New York State Common Retirement Fund14,765$0.25M0.0%+13.3%0.054%Search for SEC Filing on Google Icon
8/23/2021DC Funds LP589,102$10.27M48.8%N/A2.137%Search for SEC Filing on Google Icon
8/17/2021Sphera Funds Management LTD.706,294$12.05M0.8%N/A2.562%Search for SEC Filing on Google Icon
8/17/2021PFM Health Sciences LP400,000$6.98M0.2%N/A1.451%Search for SEC Filing on Google Icon
8/17/2021Aristides Capital LLC25,585$0.45M0.1%N/A0.093%Search for SEC Filing on Google Icon
8/17/2021Caas Capital Management LP100,000$1.74M0.0%N/A0.363%Search for SEC Filing on Google Icon
8/16/2021California State Teachers Retirement System10,465$0.18M0.0%N/A0.038%Search for SEC Filing on Google Icon
8/16/2021RA Capital Management L.P.4,291,881$74.85M1.2%N/A15.568%Search for SEC Filing on Google Icon
8/16/2021Alyeska Investment Group L.P.206,201$3.60M0.0%N/A0.748%Search for SEC Filing on Google Icon
8/16/2021Schonfeld Strategic Advisors LLC11,300$0.20M0.0%N/A0.041%Search for SEC Filing on Google Icon
8/16/2021Charles Schwab Investment Management Inc.16,038$0.28M0.0%N/A0.058%Search for SEC Filing on Google Icon
8/16/2021State Street Corp78,237$1.36M0.0%N/A0.284%Search for SEC Filing on Google Icon
8/16/2021Nuveen Asset Management LLC12,001$0.21M0.0%N/A0.044%Search for SEC Filing on Google Icon
8/16/2021Goldman Sachs Group Inc.37,435$0.65M0.0%N/A0.136%Search for SEC Filing on Google Icon
8/13/2021Northern Trust Corp75,774$1.32M0.0%N/A0.275%Search for SEC Filing on Google Icon
8/13/2021Geode Capital Management LLC108,178$1.89M0.0%N/A0.392%Search for SEC Filing on Google Icon
8/13/2021MPM Asset Management LLC4,284,172$74.72M13.9%N/A15.540%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.173,127$3.02M0.0%N/A0.628%Search for SEC Filing on Google Icon
8/13/2021MPM Oncology Impact Management LP2,388,011$41.65M6.8%N/A8.662%Search for SEC Filing on Google Icon
8/13/2021FMR LLC315,000$5.49M0.0%N/A1.143%Search for SEC Filing on Google Icon
8/12/2021JPMorgan Chase & Co.9,352$0.16M0.0%N/A0.034%Search for SEC Filing on Google Icon
8/11/2021Arena Capital Advisors LLC CA14,958$0.26M0.0%N/A0.054%Search for SEC Filing on Google Icon
8/11/2021Bank of New York Mellon Corp22,213$0.39M0.0%N/A0.081%Search for SEC Filing on Google Icon
8/11/2021BlackRock Inc.365,863$6.38M0.0%N/A1.327%Search for SEC Filing on Google Icon
8/11/2021Deutsche Bank AG4,492$78K0.0%N/A0.016%Search for SEC Filing on Google Icon
8/10/2021Nicholas Investment Partners LP294,654$5.14M0.3%N/A1.069%Search for SEC Filing on Google Icon
8/10/2021Citigroup Inc.2,016$35K0.0%N/A0.007%Search for SEC Filing on Google Icon
8/4/2021Migdal Insurance & Financial Holdings Ltd.187,500$3.27M0.0%N/A0.680%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Werewolf Therapeutics logo
Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapeutics engineered to stimulate the body's immune system for the treatment of cancer. The company, through its proprietary PREDATOR platform, designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional proinflammatory immune therapies. Its lead product candidates are WTX-124, a conditionally activated Interleukin-2 INDUKINE molecule for the treatment of advanced solid tumors; and WTX-330, a conditionally activated Interleukin-12 INDUKINE molecule for the treatment of relapsed or refractory advanced or metastatic solid tumors or lymphoma. The company is also developing WTX-613, a conditionally activated interferon alpha INDUKINE molecule for the treatment of solid tumors and hematologic malignancies. Werewolf Therapeutics, Inc. was incorporated in 2017 and is headquartered in Cambridge, Massachusetts.
Read More on Werewolf Therapeutics

Today's Range

Now: $4.54
Low: $4.54
High: $4.93

50 Day Range

MA: $4.71
Low: $3.71
High: $5.98

52 Week Range

Now: $4.54
Low: $3.51
High: $21.67

Volume

3,289 shs

Average Volume

249,786 shs

Market Capitalization

$125.55 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Werewolf Therapeutics?

Werewolf Therapeutics' top insider investors include:
  1. Bioventures 2014 LP Mpm (Major Shareholder)
  2. Ra Capital Management, LP (Director)
  3. Reid Leonard (COO)
Learn More about top insider investors at Werewolf Therapeutics.

Who are the major institutional investors of Werewolf Therapeutics?

Werewolf Therapeutics' top institutional investors include:
  1. BlackRock Inc. — 4.64%
  2. Vanguard Group Inc. — 1.89%
  3. State Street Corp — 1.21%
  4. Northern Trust Corp — 0.71%
  5. Bank of New York Mellon Corp — 0.25%
  6. Granite Point Capital Management L.P. — 0.20%
Learn More about top institutional investors of Werewolf Therapeutics stock.

Which major investors are selling Werewolf Therapeutics stock?

Within the last quarter, HOWL stock was sold by these institutional investors:
  1. JPMorgan Chase & Co.
  2. Vanguard Group Inc.
  3. Northern Trust Corp

Which major investors are buying Werewolf Therapeutics stock?

During the last quarter, HOWL stock was bought by institutional investors including:
  1. State Street Corp
  2. Granite Point Capital Management L.P.
  3. BlackRock Inc.
  4. Bank of New York Mellon Corp
  5. Rhumbline Advisers
In the last year, these company insiders have bought Werewolf Therapeutics stock:
  1. Bioventures 2014 LP Mpm (Major Shareholder)
  2. Ra Capital Management, LP (Director)
Learn More investors buying Werewolf Therapeutics stock.
How You Should Be Choosing Your Stocks
Grab your seat at our complimentary LIVE, interactive masterclass for traders. It’s your chance to finally learn how to pick the right stocks and find the best trades.

We’ll also be diving into market forecasting and revealing under-the-radar stocks we believe have significant potential in Q2.
Click here now to join and get access to our forecasting.